Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for BATF
Z-value: 2.34
Motif logo
Transcription factors associated with BATF
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
BATF
|
ENSG00000156127.8 | BATF |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| BATF | hg38_v1_chr14_+_75522531_75522560 | -0.14 | 4.6e-02 | Click! |
Activity profile of BATF motif
Sorted Z-values of BATF motif
Network of associatons between targets according to the STRING database.
First level regulatory network of BATF
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.0 | 36.0 | GO:2000224 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
| 4.7 | 23.6 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 4.6 | 27.3 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 3.5 | 13.9 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 3.1 | 12.6 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 3.1 | 12.4 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 3.1 | 34.1 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 2.9 | 14.7 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 2.9 | 8.6 | GO:0036292 | DNA rewinding(GO:0036292) |
| 2.9 | 11.5 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
| 2.8 | 8.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 2.6 | 7.9 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 2.5 | 7.5 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 2.3 | 6.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 2.2 | 13.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 2.2 | 6.5 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 2.2 | 10.8 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 2.0 | 6.0 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 2.0 | 5.9 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 1.9 | 5.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 1.9 | 5.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 1.8 | 11.0 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 1.7 | 5.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 1.7 | 6.8 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 1.7 | 10.1 | GO:0007296 | vitellogenesis(GO:0007296) |
| 1.7 | 8.3 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 1.6 | 4.9 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 1.6 | 9.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 1.6 | 6.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 1.5 | 4.6 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 1.5 | 4.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 1.5 | 7.6 | GO:0015862 | uridine transport(GO:0015862) |
| 1.5 | 14.6 | GO:0002934 | desmosome organization(GO:0002934) |
| 1.5 | 4.4 | GO:0097698 | telomere maintenance via base-excision repair(GO:0097698) |
| 1.5 | 5.8 | GO:0097325 | melanocyte proliferation(GO:0097325) |
| 1.4 | 2.8 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 1.4 | 4.2 | GO:0036233 | glycine import(GO:0036233) |
| 1.4 | 9.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 1.4 | 6.8 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 1.4 | 8.2 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 1.3 | 6.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 1.3 | 3.9 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 1.3 | 5.1 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 1.2 | 8.4 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 1.2 | 6.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 1.2 | 3.5 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 1.2 | 3.5 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 1.2 | 7.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 1.1 | 4.5 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 1.1 | 20.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 1.1 | 3.2 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 1.1 | 19.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.0 | 4.2 | GO:0009216 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
| 1.0 | 4.1 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 1.0 | 3.1 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
| 1.0 | 11.0 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 1.0 | 2.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.0 | 3.9 | GO:0002188 | translation reinitiation(GO:0002188) |
| 1.0 | 2.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.0 | 2.9 | GO:0070476 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 1.0 | 26.9 | GO:0006465 | signal peptide processing(GO:0006465) |
| 1.0 | 2.9 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
| 1.0 | 2.9 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.9 | 4.7 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.9 | 2.8 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.9 | 2.8 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.9 | 5.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.9 | 2.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.9 | 8.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.9 | 5.5 | GO:0070101 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
| 0.9 | 2.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.9 | 4.5 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.9 | 5.4 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.9 | 2.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.9 | 5.3 | GO:0061205 | alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) |
| 0.8 | 6.8 | GO:0032262 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
| 0.8 | 3.4 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.8 | 5.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.8 | 123.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.8 | 2.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.8 | 4.9 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.8 | 2.4 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.8 | 1.6 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.8 | 2.3 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.8 | 18.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.8 | 3.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.8 | 3.0 | GO:1903788 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.8 | 3.0 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.8 | 2.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.7 | 4.5 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.7 | 2.2 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.7 | 3.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.7 | 12.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.7 | 4.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.7 | 2.2 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.7 | 0.7 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.7 | 2.9 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.7 | 20.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.7 | 2.1 | GO:1901656 | glucoside transport(GO:0042946) glycoside transport(GO:1901656) |
| 0.7 | 4.2 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.7 | 5.6 | GO:2000332 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 0.7 | 4.9 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.7 | 2.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.7 | 2.0 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.7 | 20.5 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.7 | 2.6 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.7 | 2.0 | GO:0007174 | epidermal growth factor catabolic process(GO:0007174) |
| 0.6 | 1.9 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 0.6 | 8.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.6 | 1.9 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.6 | 2.6 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.6 | 2.5 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.6 | 5.6 | GO:0060613 | fat pad development(GO:0060613) |
| 0.6 | 1.9 | GO:0070409 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) cellular response to oleic acid(GO:0071400) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.6 | 8.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.6 | 8.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.6 | 1.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) regulation of chromosome condensation(GO:0060623) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.6 | 1.8 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.6 | 7.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.6 | 2.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.6 | 0.6 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.6 | 1.8 | GO:0097069 | response to human chorionic gonadotropin(GO:0044752) response to thyroxine(GO:0097068) cellular response to thyroxine stimulus(GO:0097069) response to L-phenylalanine derivative(GO:1904386) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.6 | 1.8 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.6 | 2.9 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.6 | 5.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.6 | 3.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.6 | 11.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.6 | 6.8 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.6 | 6.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.6 | 11.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.5 | 2.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.5 | 5.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.5 | 10.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.5 | 91.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.5 | 1.6 | GO:1990918 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.5 | 1.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.5 | 3.2 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
| 0.5 | 1.6 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.5 | 2.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.5 | 2.6 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.5 | 1.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.5 | 1.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.5 | 6.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.5 | 3.6 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.5 | 2.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.5 | 1.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.5 | 2.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.5 | 2.8 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.5 | 17.4 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
| 0.5 | 1.4 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.4 | 5.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.4 | 1.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.4 | 3.9 | GO:1904424 | regulation of GTP binding(GO:1904424) beta-catenin destruction complex assembly(GO:1904885) |
| 0.4 | 1.3 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.4 | 0.9 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.4 | 2.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.4 | 4.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.4 | 1.3 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.4 | 1.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 | 2.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.4 | 1.7 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.4 | 2.5 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.4 | 6.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.4 | 6.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 | 1.6 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 2.8 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.4 | 0.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.4 | 1.2 | GO:0042704 | uterine wall breakdown(GO:0042704) |
| 0.4 | 7.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.4 | 1.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 | 19.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.4 | 11.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.4 | 5.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.4 | 4.7 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.4 | 3.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.4 | 12.0 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.4 | 1.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.4 | 5.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.4 | 3.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.4 | 1.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.4 | 11.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.4 | 4.7 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.4 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.4 | 3.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.4 | 1.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.4 | 3.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.4 | 1.8 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.4 | 3.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.3 | 3.8 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.3 | 1.0 | GO:0045554 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.3 | 1.0 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.3 | 2.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.3 | 2.4 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.3 | 1.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.3 | 2.0 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.3 | 15.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.3 | 4.4 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.3 | 2.0 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.3 | 1.7 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.3 | 2.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.3 | 2.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.3 | 4.3 | GO:0042407 | cristae formation(GO:0042407) |
| 0.3 | 6.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.3 | 2.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.3 | 2.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.3 | 29.7 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.3 | 5.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.3 | 2.2 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.3 | 18.9 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.3 | 5.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 | 5.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 | 3.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.3 | 8.8 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.3 | 1.2 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.3 | 8.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.3 | 1.2 | GO:0051582 | peptidyl-cysteine methylation(GO:0018125) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.3 | 1.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.3 | 1.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.3 | 0.9 | GO:2000174 | pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.3 | 22.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.3 | 5.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.3 | 1.4 | GO:0099563 | modification of synaptic structure(GO:0099563) |
| 0.3 | 4.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.3 | 1.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.3 | 1.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.3 | 1.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.3 | 1.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.3 | 1.6 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.3 | 1.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.3 | 3.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.3 | 1.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.3 | 2.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.3 | 5.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.3 | 1.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.3 | 2.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.3 | 14.7 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
| 0.3 | 1.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.2 | 4.2 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.2 | 0.7 | GO:0002503 | peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 | 1.5 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 | 9.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.2 | 1.9 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.2 | 3.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 | 2.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 1.4 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 | 1.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.2 | 2.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.2 | 2.6 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.2 | 1.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.2 | 0.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 | 2.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.2 | 1.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 | 0.9 | GO:1903758 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 | 1.6 | GO:0030421 | defecation(GO:0030421) |
| 0.2 | 4.7 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 0.2 | 4.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 | 0.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.2 | 1.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 0.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.2 | 3.9 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 0.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 | 3.0 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.2 | 0.9 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.2 | 1.3 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 | 2.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.2 | 21.0 | GO:0070268 | cornification(GO:0070268) |
| 0.2 | 1.3 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
| 0.2 | 5.7 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.2 | 10.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 | 2.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.2 | 0.8 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.2 | 1.4 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.2 | 1.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 0.8 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 4.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.2 | 0.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.2 | 2.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 | 2.4 | GO:0007567 | parturition(GO:0007567) |
| 0.2 | 0.7 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.2 | 7.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.2 | 0.9 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.2 | 0.7 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 | 11.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.2 | 0.2 | GO:0032071 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.2 | 1.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.2 | 4.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.2 | 1.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.2 | 3.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.2 | 0.7 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 0.8 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.2 | 0.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 5.7 | GO:0061641 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 | 1.8 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.2 | 1.0 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.2 | 4.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.2 | 0.5 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
| 0.2 | 1.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 | 2.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.2 | 1.7 | GO:0009629 | response to gravity(GO:0009629) |
| 0.2 | 0.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.2 | 1.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.2 | 0.8 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.2 | 3.2 | GO:0000732 | strand displacement(GO:0000732) |
| 0.2 | 1.4 | GO:0030728 | ovulation(GO:0030728) |
| 0.2 | 2.6 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.2 | 2.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.2 | 1.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 1.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 2.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 10.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.1 | 4.2 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.1 | 1.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 | 0.9 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.4 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.1 | 3.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 4.1 | GO:0006625 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 | 0.4 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
| 0.1 | 0.9 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 2.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 | 0.5 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.1 | 2.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 | 1.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 | 1.5 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 | 1.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.1 | 0.1 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
| 0.1 | 8.9 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.1 | 1.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.8 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 | 0.2 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.1 | 2.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 | 1.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 | 11.7 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.1 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 | 0.8 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 | 2.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.1 | 2.0 | GO:0019724 | B cell mediated immunity(GO:0019724) |
| 0.1 | 0.8 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 4.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.1 | 0.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.8 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.1 | 2.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 0.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 | 0.5 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.1 | 0.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 1.7 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 | 1.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 1.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.1 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 | 1.2 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 7.1 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.1 | 10.4 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.1 | 3.4 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 1.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 2.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.1 | 0.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 | 0.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 2.6 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
| 0.1 | 1.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 0.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.1 | 0.4 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.1 | 1.2 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.1 | 1.6 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
| 0.1 | 5.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 0.4 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
| 0.1 | 1.0 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 1.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 | 0.4 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.1 | 0.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 | 3.0 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.1 | 0.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.3 | GO:0039516 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) modulation by virus of host apoptotic process(GO:0039526) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.1 | 1.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 1.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 | 3.6 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 0.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.1 | 3.6 | GO:0006342 | chromatin silencing(GO:0006342) |
| 0.1 | 3.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 1.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 1.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
| 0.1 | 1.4 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 3.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 1.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 3.1 | GO:0034644 | cellular response to UV(GO:0034644) |
| 0.1 | 1.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 10.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.1 | 4.2 | GO:0031294 | lymphocyte costimulation(GO:0031294) |
| 0.1 | 1.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 1.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 0.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 0.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.4 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
| 0.1 | 2.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.1 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.1 | 0.4 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 | 1.1 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.1 | 1.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.1 | 0.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 | 1.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.7 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 | 1.6 | GO:0071806 | protein transmembrane transport(GO:0071806) |
| 0.0 | 0.1 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.0 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 | 1.7 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 | 0.7 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
| 0.0 | 0.1 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.0 | 0.8 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.0 | 1.4 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 0.4 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 0.0 | 2.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
| 0.0 | 0.5 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.0 | 3.0 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 0.2 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
| 0.0 | 1.6 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.0 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.0 | 1.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.0 | 0.4 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.0 | 0.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.0 | 1.9 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
| 0.0 | 1.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 | 0.1 | GO:0046874 | quinolinate biosynthetic process(GO:0019805) quinolinate metabolic process(GO:0046874) |
| 0.0 | 7.5 | GO:0008380 | RNA splicing(GO:0008380) |
| 0.0 | 0.1 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar cortex formation(GO:0021697) cerebellar granule cell differentiation(GO:0021707) |
| 0.0 | 0.5 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 | 1.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 0.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 | 0.5 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 0.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.0 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.0 | 0.0 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 | 0.8 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 0.0 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.4 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.3 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 | 2.2 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.0 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 | 0.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 | 1.4 | GO:0001649 | osteoblast differentiation(GO:0001649) |
| 0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.7 | 11.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 3.0 | 26.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 2.9 | 11.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 2.8 | 11.0 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 2.6 | 12.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 2.5 | 12.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 2.5 | 27.3 | GO:0005638 | lamin filament(GO:0005638) |
| 2.4 | 7.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 2.0 | 5.9 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 1.9 | 13.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 1.6 | 4.9 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 1.6 | 34.4 | GO:0097342 | ripoptosome(GO:0097342) |
| 1.6 | 16.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 1.6 | 3.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 1.5 | 1.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 1.5 | 10.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 1.3 | 7.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 1.3 | 7.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 1.2 | 8.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 1.2 | 3.5 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 1.2 | 3.5 | GO:0044393 | microspike(GO:0044393) |
| 1.2 | 5.8 | GO:0032449 | CBM complex(GO:0032449) |
| 1.1 | 7.5 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
| 1.1 | 8.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 1.0 | 16.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 1.0 | 3.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.9 | 4.6 | GO:1990425 | terminal cisterna(GO:0014802) ryanodine receptor complex(GO:1990425) |
| 0.9 | 11.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.9 | 3.4 | GO:0000811 | GINS complex(GO:0000811) |
| 0.9 | 4.3 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.8 | 10.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.8 | 7.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.8 | 42.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.8 | 3.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.8 | 18.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.7 | 5.8 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.7 | 8.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.7 | 3.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.7 | 2.8 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.7 | 7.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.7 | 2.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.7 | 2.0 | GO:0032419 | extrinsic component of lysosome membrane(GO:0032419) |
| 0.7 | 8.5 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.6 | 1.9 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.6 | 2.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 0.6 | 2.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.6 | 5.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.6 | 10.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.6 | 1.8 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.6 | 7.4 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.5 | 6.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.5 | 2.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.5 | 2.7 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.5 | 1.9 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.5 | 14.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.5 | 2.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.5 | 3.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.5 | 6.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.5 | 10.9 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.4 | 5.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.4 | 7.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.4 | 1.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.4 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.4 | 10.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.4 | 2.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.4 | 2.3 | GO:1990357 | terminal web(GO:1990357) |
| 0.4 | 12.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.4 | 11.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.4 | 32.2 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.4 | 11.2 | GO:0071437 | invadopodium(GO:0071437) |
| 0.3 | 7.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.3 | 5.0 | GO:0008091 | spectrin(GO:0008091) |
| 0.3 | 3.7 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.3 | 13.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.3 | 6.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.3 | 9.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.3 | 5.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.3 | 1.8 | GO:0044754 | autolysosome(GO:0044754) |
| 0.3 | 2.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.3 | 1.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.3 | 46.2 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.3 | 6.1 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.3 | 1.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.3 | 4.0 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.3 | 2.5 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.3 | 11.2 | GO:0032420 | stereocilium(GO:0032420) |
| 0.3 | 3.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.3 | 1.3 | GO:0043256 | laminin complex(GO:0043256) |
| 0.3 | 2.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.2 | 1.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.2 | 3.0 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.2 | 2.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.2 | 26.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.2 | 1.7 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.2 | 3.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.2 | 2.4 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.2 | 1.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.2 | 6.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.2 | 12.8 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 2.9 | GO:0097413 | Lewy body(GO:0097413) |
| 0.2 | 46.1 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.2 | 2.4 | GO:0042555 | MCM complex(GO:0042555) |
| 0.2 | 0.8 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.2 | 3.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 2.4 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 3.9 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 1.8 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.2 | 0.9 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.2 | 5.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.2 | 1.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 17.2 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.2 | 2.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 3.3 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.2 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.2 | 1.1 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.2 | 10.9 | GO:0015030 | Cajal body(GO:0015030) |
| 0.2 | 1.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.2 | 5.6 | GO:0002102 | podosome(GO:0002102) |
| 0.2 | 8.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 8.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 4.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 12.9 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 1.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.6 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 2.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 1.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.1 | 4.0 | GO:0030684 | preribosome(GO:0030684) |
| 0.1 | 8.6 | GO:0005840 | ribosome(GO:0005840) |
| 0.1 | 8.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 13.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.1 | 0.6 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 1.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 10.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.1 | 0.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 8.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.5 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.1 | 1.3 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 2.1 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 0.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.7 | GO:0001939 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
| 0.1 | 4.3 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 2.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 1.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 3.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 1.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 5.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 1.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.1 | 3.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.1 | 3.0 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 6.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 17.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.1 | 1.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 1.7 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.1 | 1.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 1.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 0.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.1 | 1.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 26.9 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 6.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 0.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 0.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.2 | GO:0035061 | Smc5-Smc6 complex(GO:0030915) interchromatin granule(GO:0035061) |
| 0.1 | 0.9 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 16.0 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 1.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 0.3 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 3.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 2.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 3.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 12.9 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 3.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.0 | 0.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.0 | 16.6 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
| 0.0 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.0 | 0.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.0 | 3.1 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 1.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 131.4 | GO:0044421 | extracellular region part(GO:0044421) |
| 0.0 | 0.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.0 | 2.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) INO80-type complex(GO:0097346) |
| 0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.0 | 0.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.0 | 1.2 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 0.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.0 | 1.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 0.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 1.6 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.0 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.0 | 4.4 | GO:0005635 | nuclear envelope(GO:0005635) |
| 0.0 | 0.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.0 | 36.0 | GO:0047787 | geranylgeranyl reductase activity(GO:0045550) delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 7.5 | 7.5 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
| 3.9 | 19.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 3.2 | 6.4 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 2.9 | 11.6 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 2.7 | 8.2 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 2.7 | 10.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 2.6 | 7.9 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 2.5 | 7.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 2.5 | 7.4 | GO:0051717 | phosphohistidine phosphatase activity(GO:0008969) bisphosphoglycerate phosphatase activity(GO:0034416) inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
| 2.3 | 6.8 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 2.1 | 10.3 | GO:1990254 | keratin filament binding(GO:1990254) |
| 2.0 | 6.0 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 1.9 | 7.6 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 1.9 | 9.3 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 1.8 | 18.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 1.7 | 10.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 1.7 | 6.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 1.7 | 10.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 1.7 | 5.0 | GO:0070538 | oleic acid binding(GO:0070538) |
| 1.6 | 4.9 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 1.5 | 6.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 1.4 | 4.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 1.3 | 5.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 1.2 | 36.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 1.2 | 7.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 1.1 | 5.6 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.1 | 4.4 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 1.1 | 4.4 | GO:0019862 | IgA binding(GO:0019862) |
| 1.1 | 5.4 | GO:0045174 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 1.1 | 4.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 1.0 | 7.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 1.0 | 8.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.0 | 4.2 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 1.0 | 4.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 1.0 | 4.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 1.0 | 5.0 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 1.0 | 3.0 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 1.0 | 5.9 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 1.0 | 2.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.9 | 24.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.9 | 2.8 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.9 | 5.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.9 | 214.6 | GO:0003823 | antigen binding(GO:0003823) |
| 0.9 | 4.5 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.9 | 4.5 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.9 | 3.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.9 | 3.6 | GO:0043273 | CTPase activity(GO:0043273) |
| 0.9 | 2.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.9 | 6.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.8 | 10.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.8 | 8.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.8 | 4.9 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.8 | 26.3 | GO:0001848 | complement binding(GO:0001848) |
| 0.8 | 3.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.8 | 11.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.8 | 3.0 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.7 | 2.2 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.7 | 5.8 | GO:0019863 | IgE binding(GO:0019863) |
| 0.7 | 4.3 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.7 | 2.1 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.7 | 5.6 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.7 | 2.8 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.7 | 3.4 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.7 | 3.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 0.7 | 4.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.7 | 4.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.7 | 0.7 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.7 | 3.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.7 | 5.9 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 0.6 | 3.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.6 | 3.2 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.6 | 2.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.6 | 2.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.6 | 1.8 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.6 | 3.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.6 | 1.8 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.6 | 1.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.6 | 1.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.6 | 15.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.6 | 5.6 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.6 | 2.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.5 | 2.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.5 | 13.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.5 | 1.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.5 | 2.6 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.5 | 21.6 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.5 | 4.6 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.5 | 3.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.5 | 2.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.5 | 1.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.5 | 1.9 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.5 | 6.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.5 | 5.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.5 | 1.9 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.4 | 1.3 | GO:0000035 | acyl binding(GO:0000035) |
| 0.4 | 1.8 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.4 | 1.3 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.4 | 18.7 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.4 | 2.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.4 | 12.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.4 | 4.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.4 | 4.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.4 | 1.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.4 | 9.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.4 | 2.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.4 | 11.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.4 | 1.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.4 | 1.9 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.4 | 7.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.4 | 9.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.4 | 1.5 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.4 | 1.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.4 | 12.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.4 | 2.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.4 | 2.5 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.4 | 2.8 | GO:0046790 | virion binding(GO:0046790) |
| 0.3 | 3.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.3 | 2.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.3 | 1.7 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.3 | 2.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.3 | 1.0 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.3 | 7.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.3 | 2.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.3 | 1.0 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
| 0.3 | 15.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.3 | 4.3 | GO:0031386 | protein tag(GO:0031386) |
| 0.3 | 4.0 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.3 | 2.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.3 | 2.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.3 | 1.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 13.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.3 | 0.9 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.3 | 1.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.3 | 6.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.3 | 1.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.3 | 6.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.3 | 9.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.3 | 2.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.3 | 2.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.3 | 3.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.3 | 2.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.3 | 3.5 | GO:1901567 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 0.2 | 0.5 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.2 | 3.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.2 | 7.8 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.2 | 2.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.2 | 8.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.2 | 1.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 4.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 61.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.2 | 6.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.2 | 7.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 9.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.2 | 2.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.2 | 0.7 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.2 | 2.2 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.2 | 5.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 2.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.2 | 8.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 1.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 2.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.2 | 1.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.2 | 0.8 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.2 | 6.4 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.2 | 1.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.2 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.2 | 3.2 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 0.8 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
| 0.2 | 3.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.2 | 13.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.2 | 14.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.2 | 13.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.2 | 2.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.2 | 1.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.2 | 1.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.2 | 0.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.2 | 2.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 3.4 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 1.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.2 | 0.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 0.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.2 | 0.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.2 | 3.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.2 | 3.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.2 | 2.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 10.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.2 | 3.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.2 | 1.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 2.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 2.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 5.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.1 | 0.7 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 1.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 0.6 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.1 | 2.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 2.2 | GO:0016594 | glycine binding(GO:0016594) |
| 0.1 | 1.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 7.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 1.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 4.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.1 | 4.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 0.5 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.1 | 0.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.1 | 1.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 1.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.1 | 22.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 2.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 0.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.1 | 3.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 0.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 1.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 4.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 6.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 5.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 2.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 1.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 4.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 3.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.1 | 3.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 4.4 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.3 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.1 | 1.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 7.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 4.8 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.1 | 0.5 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.1 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 3.1 | GO:0019825 | oxygen binding(GO:0019825) |
| 0.1 | 1.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.3 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.1 | 0.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 5.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 4.8 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.1 | 0.4 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.1 | 5.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 0.3 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.1 | 1.0 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.1 | 3.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 2.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 3.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 4.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 5.8 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 2.4 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 5.7 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 3.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 1.1 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 12.9 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.1 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.1 | 2.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 2.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 0.4 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.1 | 0.5 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.1 | 1.7 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.1 | 0.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.1 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 2.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 4.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 2.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.1 | 0.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.0 | 3.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 1.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.0 | 3.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.1 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.0 | 0.1 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.0 | 0.8 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
| 0.0 | 12.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 0.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.0 | 0.2 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.0 | 1.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 1.1 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.1 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.0 | 6.4 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 1.0 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 2.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 3.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 1.4 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.2 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.0 | 0.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.0 | 3.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.0 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.0 | 0.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 2.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.0 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.0 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 0.7 | GO:0020037 | heme binding(GO:0020037) |
| 0.0 | 0.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.0 | 0.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 3.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 1.1 | 34.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 1.0 | 2.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.8 | 14.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.7 | 43.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.5 | 25.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.5 | 1.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.4 | 39.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.4 | 9.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.4 | 17.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.4 | 26.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.3 | 7.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 13.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.3 | 30.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.3 | 24.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.3 | 8.4 | PID MYC PATHWAY | C-MYC pathway |
| 0.3 | 2.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.3 | 9.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.3 | 3.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.3 | 8.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.3 | 10.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.2 | 6.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.2 | 13.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 1.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.2 | 1.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.2 | 5.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 14.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.2 | 12.2 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.2 | 6.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.2 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 8.9 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.2 | 4.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.2 | 8.5 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.2 | 3.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 2.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 4.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 3.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 1.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 3.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 1.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 3.9 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 2.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 5.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 3.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 3.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 2.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 3.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 5.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 1.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 1.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 4.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 2.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 7.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 1.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 2.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 7.1 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 5.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 5.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 1.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 1.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 13.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 2.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.1 | 15.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 0.8 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 0.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 2.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 2.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 5.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 15.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 1.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.0 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 2.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 4.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 6.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.0 | 2.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.9 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 1.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 28.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 1.4 | 4.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 1.4 | 20.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 1.2 | 11.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 1.1 | 34.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 1.0 | 14.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.9 | 9.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.8 | 9.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.8 | 6.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.7 | 28.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.6 | 9.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.6 | 10.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.6 | 19.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.6 | 6.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.6 | 12.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.6 | 50.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.5 | 13.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.5 | 16.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.5 | 7.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.5 | 17.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.4 | 0.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.4 | 21.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.4 | 1.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.4 | 10.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.4 | 9.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.4 | 11.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.4 | 11.4 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.4 | 6.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.4 | 5.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.4 | 4.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.4 | 15.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.4 | 7.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.4 | 7.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.4 | 10.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.3 | 5.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.3 | 9.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.3 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.3 | 7.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.3 | 7.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.3 | 12.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.3 | 5.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.3 | 6.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.3 | 7.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.3 | 5.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.3 | 4.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.3 | 9.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.3 | 3.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.2 | 3.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.2 | 5.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 26.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.2 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 27.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.2 | 8.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 4.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.2 | 2.6 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 0.2 | 9.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.2 | 1.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 2.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.2 | 4.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 4.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 8.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.2 | 3.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.2 | 2.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 3.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.2 | 2.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.2 | 3.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.2 | 1.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.2 | 7.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 2.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.2 | 3.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.2 | 5.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 9.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.2 | 2.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 9.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 19.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 3.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 2.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 3.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.1 | 3.6 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
| 0.1 | 21.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 0.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.1 | 5.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 1.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 4.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.1 | 5.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 2.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 2.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 3.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 2.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 16.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 5.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 2.2 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
| 0.1 | 1.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 1.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 1.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 1.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 9.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.1 | 2.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 2.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 2.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 2.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 1.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 3.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.1 | 4.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 4.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 0.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 2.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 1.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 3.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 1.1 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.0 | 1.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 1.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 0.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.0 | 1.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.0 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 1.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.0 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.0 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.0 | 0.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 0.3 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
| 0.0 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.0 | 1.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.0 | 0.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |